Mechanisms of platelet retention in the collagen-coated–bead column

[1]  F. Ofosu,et al.  The Blood Platelet as a Model for Regulating Blood Coagulation on Cell Surfaces and Its Consequences , 2004, Biochemistry (Moscow).

[2]  Shinya Goto,et al.  Application of Ex Vivo Flow Chamber System for Assessment of Stent Thrombosis , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[3]  S. Goto,et al.  Involvement of Glycoprotein VI in Platelet Thrombus Formation on Both Collagen and von Willebrand Factor Surfaces Under Flow Conditions , 2002, Circulation.

[4]  P. Nurden,et al.  Role of ADP Receptor P2Y12 in Platelet Adhesion and Thrombus Formation in Flowing Blood , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[5]  C. Gachet Identification, Characterization, and Inhibition of the Platelet ADP Receptors , 2001, International journal of hematology.

[6]  J. Moake,et al.  Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow. , 2001, Blood.

[7]  B. Jilma Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. , 2001, The Journal of laboratory and clinical medicine.

[8]  T. Nakano,et al.  Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease. , 2001, American heart journal.

[9]  K. Clemetson,et al.  Platelet Collagen Receptors , 2001, Thrombosis and Haemostasis.

[10]  M. Berndt,et al.  The Vascular Biology of the Glycoprotein Ib-IX-V Complex , 2001, Thrombosis and Haemostasis.

[11]  C. Gachet ADP Receptors of Platelets and their Inhibition , 2001, Thrombosis and Haemostasis.

[12]  M. Morice,et al.  Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. , 2001, The New England journal of medicine.

[13]  F. Monsma,et al.  Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. , 2001, The Journal of clinical investigation.

[14]  E. Favaloro,et al.  Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder. , 2001, Best practice & research. Clinical haematology.

[15]  B. Nieswandt,et al.  Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen , 2001 .

[16]  Jan Kroon,et al.  Identification of the Collagen-binding Site of the von Willebrand Factor A3-domain* , 2001, The Journal of Biological Chemistry.

[17]  Y. Wu,et al.  Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia/IIa (GPIa/IIa, Integrin alpha 2beta 1). Involvement of GPIa/IIa-associated src and protein tyrosine phosphorylation. , 2001, The Journal of biological chemistry.

[18]  David Julius,et al.  Identification of the platelet ADP receptor targeted by antithrombotic drugs , 2001, Nature.

[19]  S. Goto,et al.  Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation , 2001, Platelets.

[20]  R. Storey The P2Y 12 receptor as a therapeutic target in cardiovascular disease , 2001, Platelets.

[21]  Pille Harrison,et al.  Progress in the assessment of platelet function. , 2000, British journal of haematology.

[22]  B. Weksler Antiplatelet Agents in Stroke Prevention , 2000, Cerebrovascular Diseases.

[23]  J. Herbert,et al.  Identification and Biological Activity of the Active Metabolite of Clopidogrel , 2000, Thrombosis and Haemostasis.

[24]  K. Titani,et al.  Activation of protein-tyrosine kinase pathways in human platelets stimulated with the A1 domain of von Willebrand factor. , 2000, Platelets.

[25]  P Mangin,et al.  A revised model of platelet aggregation. , 2000, The Journal of clinical investigation.

[26]  H. Yamamoto,et al.  AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Brian Savage,et al.  Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow , 1998, Cell.

[28]  A. Frelinger,et al.  Novel methods for assessing platelet function. , 1998, American heart journal.

[29]  R. Knöfler,et al.  Release of adenosine triphosphate by adenosine diphosphate in whole blood and in erythrocyte suspensions , 1997, American journal of hematology.

[30]  M. Carr In vitro assessment of platelet function. , 1997, Transfusion medicine reviews.

[31]  B. Coller Perspectives Series: Cell Adhesion in Vascular Biology Platelet Gpiib/iiia Antagonists: the First Anti-integrin Receptor Therapeutics , 2022 .

[32]  B. Coller,et al.  Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade. , 1997, Circulation.

[33]  M. Díaz-Ricart,et al.  Analysis of platelet adhesion to a collagen-coated surface under flow conditions: the involvement of glycoprotein VI in the platelet adhesion. , 1996, Blood.

[34]  Y. Yatomi,et al.  Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotonin. , 1996, Thrombosis research.

[35]  A. Marcus,et al.  Thrombosis and Inflammation as Multicellular Processes: Significance of Cell-Cell Interactions , 1995, Thrombosis and Haemostasis.

[36]  H. Weiss Flow-Related Platelet Deposition on Subendothelium , 1995, Thrombosis and Haemostasis.

[37]  K. Fukutake,et al.  Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency , 1995, British journal of haematology.

[38]  Marcus Aj Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. , 1994 .

[39]  R. Beissinger,et al.  Artificial surface effect on red blood cells and platelets in laminar shear flow. , 1990, Blood.

[40]  M. Naka,et al.  Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis. , 1989, European journal of pharmacology.

[41]  S. Santoro Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen , 1986, Cell.

[42]  E. Lapetina,et al.  Inositol 1,4,5-trisphosphate induces aggregation and release of 5-hydroxytryptamine from saponin-permeabilized human platelets. , 1986, The Journal of biological chemistry.

[43]  S. Barondes,et al.  Adhesion of human platelets to immobilized trimeric collagen , 1982, The Journal of cell biology.

[44]  E. Freireich,et al.  Standardization of platelet function tests , 1981, American journal of hematology.

[45]  J. Mcpherson,et al.  Platelet retention in glass bead columns: adhesion to glass and subsequent platelet-platelet interactions. , 1976, Blood.

[46]  H. Weiss Platelet Physiology and Abnormalities of Platelet Function , 1975 .

[47]  H. Weiss Platelet physiology and abnormalities of platelet function (second of two parts). , 1975, The New England journal of medicine.

[48]  H. Baumgartner,et al.  The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. , 1973, Microvascular research.

[49]  C. Haudenschild,et al.  ADHESION OF PLATELETS TO SUBENDOTHELIUM , 1972, Annals of the New York Academy of Sciences.

[50]  E. Rossi,et al.  A Study of Platelet Retention by Glass Bead Columns (‘Platelet Adhesiveness’ in Normal Subjects) , 1972, British journal of haematology.

[51]  A. Hellem Platelet adhesiveness in von Willebrand's disease. A study with a new modification of the glass bead filter method. , 2009, Scandinavian journal of haematology.

[52]  L. Aledort,et al.  The effect of salicylates on the hemostatic properties of platelets in man. , 1968, The Journal of clinical investigation.

[53]  E. Salzman MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE. , 1963, The Journal of laboratory and clinical medicine.

[54]  G. Born,et al.  Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.